Cabantchik, Z. Ioav

The labile iron pool: characterization, measurement, and participation in cellular processes1 1This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.

Kakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 839

Labile plasma iron in iron overload: redox activity and susceptibility to chelation

Esposito, B. P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C., & Cabantchik, Z. I. (2003) · Blood

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 475

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood

Neurological diseases and metabolismIron Metabolism and Disorders

Cited by 409

Fluorescence analysis of the labile iron pool of mammalian cells

Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W., & Cabantchik, Z. I. (1997) · Analytical Biochemistry

Iron Metabolism and DisordersMolecular Sensors and Ion Detection

Cited by 391

Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II)

Breuer, W., Epsztejn, S., & Cabantchik, Z. I. (1995) · Journal of Biological Chemistry

Iron Metabolism and DisordersPlant Micronutrient Interactions and Effects

Cited by 326

Labile iron in cells and body fluids: Physiology, pathology, and pharmacology

Cabantchik, Z. I. (2014) · Frontiers in Pharmacology

Iron Metabolism and DisordersTrace Elements in Health

Cited by 306

H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties

Epsztejn, S., Glickstein, H., Picard, V., Slotki, I. N., Breuer, W., Beaumont, C., & Cabantchik, Z. I. (1999) · Blood

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 209

Transferrin therapy ameliorates disease in β-thalassemic mice

Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 192

Intracellular labile iron

Breuer, W., Shvartsman, M., & Cabantchik, Z. I. (2008) · The International Journal of Biochemistry & Cell Biology

Iron Metabolism and DisordersTrace Elements in Health

Cited by 175

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

Sohn, Y.-S., Breuer, W., Munnich, A., & Cabantchik, Z. I. (2008) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 167

Redox active plasma iron in C282Y/C282Y hemochromatosis

Le Lan, C., Loréal, O., Cohen, T., Ropert, M., Glickstein, H., Lainé, F., Pouchard, M., Deugnier, Y., Le Treut, A., Breuer, W., et al. (2005) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 151

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Jacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry

Iron Metabolism and DisordersClinical Laboratory Practices and Quality Control

Cited by 101

The role of endocytic pathways in cellular uptake of plasma non-transferrin iron

Sohn, Y.-S., Ghoti, H., Breuer, W., Rachmilewitz, E., Attar, S., Weiss, G., & Cabantchik, Z. I. (2012) · Haematologica

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 44